About Us
aTyr Pharma discovers and develops protein therapeutics for human diseases. We are building a comprehensive intellectual property portfolio across a family of proteins, the Physiocrine™ family, and their biologically active components.
Physiocrines™ have therapeutic potential across a wide range of disease areas including vascular, inflammation, oncology, metabolic, neurologic and dermatologic disorders. Two Physiocrine™ biologics are currently in pre-clinical development.
aTyr Pharma also has established domestic and international collaborative corporate and academic partners for pre-clinical research and development. aTyr Pharma will select products from the development pipeline for internal development, corporate partnerships, and out-licensing.